AAAAAA

   
Results: 1-25 |
Results: 25
PHARMACOKINETICS AND DOSE PROPORTIONALITY OF SP W-4853, THE MAIN METABOLITE OF SP/W-5186 A NEW ORGANIC NITRATE/
Authors: BONN R BOKENS H HAMMES W TRENK D SEIBERLING M JAHNCHEN E
Citation: R. Bonn et al., PHARMACOKINETICS AND DOSE PROPORTIONALITY OF SP W-4853, THE MAIN METABOLITE OF SP/W-5186 A NEW ORGANIC NITRATE/, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 627-627
QUANTITATIVE-ANALYSIS OF THE CONTRIBUTION OF THE METABOLITE ISOSORBIDE-5-MONONITRATE TO THE HEMODYNAMIC EFFECTIVENESS OF ISOSORBIDE DINITRATE
Authors: TRENK D KOHLER H DILGER K STENGELE E JAHNCHEN E
Citation: D. Trenk et al., QUANTITATIVE-ANALYSIS OF THE CONTRIBUTION OF THE METABOLITE ISOSORBIDE-5-MONONITRATE TO THE HEMODYNAMIC EFFECTIVENESS OF ISOSORBIDE DINITRATE, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 629-629
HEMODYNAMIC-EFFECTS OF THE NEW NO-RELEASING COMPOUND SP W-5186 IN HEALTHY-VOLUNTEERS - COMPARISON WITH ISOSORBIDE-5-MONONITRATE/
Authors: TRENK D HINDER M FUNG E STENGELE E BONN R JAHNCHEN E
Citation: D. Trenk et al., HEMODYNAMIC-EFFECTS OF THE NEW NO-RELEASING COMPOUND SP W-5186 IN HEALTHY-VOLUNTEERS - COMPARISON WITH ISOSORBIDE-5-MONONITRATE/, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 658-658
ARE HEMODYNAMIC SURROGATE PARAMETERS OF NO-RELEASING DRUGS IN HEALTHY-VOLUNTEERS SUITABLE PREDICTORS OF THE ANTIISCHEMIC AND ANTIANGINAL EFFECTS IN PATIENTS
Authors: TRENK D STENGELE E ROSKAMM H JAHNCHEN E
Citation: D. Trenk et al., ARE HEMODYNAMIC SURROGATE PARAMETERS OF NO-RELEASING DRUGS IN HEALTHY-VOLUNTEERS SUITABLE PREDICTORS OF THE ANTIISCHEMIC AND ANTIANGINAL EFFECTS IN PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 22-22
MAJOR CONTRIBUTION OF THE FORMED METABOLITE ISOSORBIDE-5-MONONITRATE TO THE HEMODYNAMIC-EFFECTS OF ISOSORBIDE DINITRATE 120 MG
Authors: KOHLER H TRENK D DILGER K STENGELE E JAHNCHEN E
Citation: H. Kohler et al., MAJOR CONTRIBUTION OF THE FORMED METABOLITE ISOSORBIDE-5-MONONITRATE TO THE HEMODYNAMIC-EFFECTS OF ISOSORBIDE DINITRATE 120 MG, Clinical pharmacology and therapeutics, 63(2), 1998, p.
AGE-DEPENDENT DIFFERENCES IN THE ANTICOAGULANT EFFECT OF PHENPROCOUMON IN PATIENTS AFTER HEART-VALVE SURGERY
Authors: RUSSMANN S GOHLKEBARWOLF C JAHNCHEN E TRENK D ROSKAMM H
Citation: S. Russmann et al., AGE-DEPENDENT DIFFERENCES IN THE ANTICOAGULANT EFFECT OF PHENPROCOUMON IN PATIENTS AFTER HEART-VALVE SURGERY, European Journal of Clinical Pharmacology, 52(1), 1997, pp. 31-35
ANTIISCHEMIC EFFECTS OF CORMIN FOLLOWING INFUSION FOR 24 HOURS
Authors: STENGELE E DILGER K WINKELMANN B SCHULZ W LOFFLER K JAHNCHEN E TRENK D ROSKAMM H
Citation: E. Stengele et al., ANTIISCHEMIC EFFECTS OF CORMIN FOLLOWING INFUSION FOR 24 HOURS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 422-422
ASSESSMENT OF HEMODYNAMIC SURROGATE PARAMETERS OF NO-DONORS IN HEALTHY-VOLUNTEERS - PREDICTORS OF THE ANTIISCHEMIC AND ANTIANGINAL EFFECTS IN PATIENTS WITH CORONARY HEART-DISEASE
Authors: TRENK D STENGELE E LOFFLER K ROSKAMM H JAHNCHEN E
Citation: D. Trenk et al., ASSESSMENT OF HEMODYNAMIC SURROGATE PARAMETERS OF NO-DONORS IN HEALTHY-VOLUNTEERS - PREDICTORS OF THE ANTIISCHEMIC AND ANTIANGINAL EFFECTS IN PATIENTS WITH CORONARY HEART-DISEASE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 423-423
DETERMINATION OF THE DOSE-RESPONSE RELATIONSHIPS OF THE HEMODYNAMIC-EFFECTS OF THE NOVEL SYDNONIMINE DERIVATIVE PIRSIDOMINE
Authors: TRENK D WALCHER P WEEGER R LOFFLER K JAHNCHEN E
Citation: D. Trenk et al., DETERMINATION OF THE DOSE-RESPONSE RELATIONSHIPS OF THE HEMODYNAMIC-EFFECTS OF THE NOVEL SYDNONIMINE DERIVATIVE PIRSIDOMINE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 435-435
NONINVASIVE DETERMINATION OF CARDIODEPRESSANT EFFECTS OF PROPAFENONE BY IMPEDANCE CARDIOGRAPHY
Authors: STENGELE E HINDER M TRENK D MULLERPELTZER H EICHELBAUM M JAHNCHEN E
Citation: E. Stengele et al., NONINVASIVE DETERMINATION OF CARDIODEPRESSANT EFFECTS OF PROPAFENONE BY IMPEDANCE CARDIOGRAPHY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 484-484
A PHARMACODYNAMIC AND PHARMACOKINETIC COMPARISON OF INTRAVENOUS QUINAPRILAT AND ORAL QUINAPRIL
Authors: BRESLIN E POSVAR E NEUB M TRENK D JAHNCHEN E
Citation: E. Breslin et al., A PHARMACODYNAMIC AND PHARMACOKINETIC COMPARISON OF INTRAVENOUS QUINAPRILAT AND ORAL QUINAPRIL, Journal of clinical pharmacology, 36(5), 1996, pp. 414-421
DIGITAL PULSE PLETHYSMOGRAPHY AS A NONINVASIVE METHOD FOR PREDICTING DRUG-INDUCED CHANGES IN LEFT-VENTRICULAR PRELOAD
Authors: STENGELE E WINKLER F TRENK D JAHNCHEN E PETERSEN J ROSKAMM H
Citation: E. Stengele et al., DIGITAL PULSE PLETHYSMOGRAPHY AS A NONINVASIVE METHOD FOR PREDICTING DRUG-INDUCED CHANGES IN LEFT-VENTRICULAR PRELOAD, European Journal of Clinical Pharmacology, 50(4), 1996, pp. 279-282
DOSE RANGE STUDY OF THE HEMODYNAMIC-EFFECTS OF REPEATED ORAL DOSES OF30, 60 AND 120 MG OF ISOSORBIDE-5-MONONITRATE IN COMPARISON WITH PLACEBO
Authors: TRENK D PFEFFERLE B JONSSON UE JAHNCHEN E
Citation: D. Trenk et al., DOSE RANGE STUDY OF THE HEMODYNAMIC-EFFECTS OF REPEATED ORAL DOSES OF30, 60 AND 120 MG OF ISOSORBIDE-5-MONONITRATE IN COMPARISON WITH PLACEBO, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 10-10
TIME PROFILE OF ACE-ACTIVITY IN PLASMA FOLLOWING IV-BOLUS DOSE OR IV-INFUSION OF THE ACE-INHIBITOR QUINAPRILAT
Authors: TRENK D DILGER K STENGELE E LOGEMANN C JAHNCHEN E
Citation: D. Trenk et al., TIME PROFILE OF ACE-ACTIVITY IN PLASMA FOLLOWING IV-BOLUS DOSE OR IV-INFUSION OF THE ACE-INHIBITOR QUINAPRILAT, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 43-43
SHORT-TERM HEMODYNAMIC, ANTIISCHEMIC, AND ANTIANGINAL EFFECTS OF PIRSIDOMINE, A NEW SYDNONIMINE
Authors: STENGELE E RUF G JAHNCHEN E TRENK D LOFFLER K SCHULZ W ROSKAMM H
Citation: E. Stengele et al., SHORT-TERM HEMODYNAMIC, ANTIISCHEMIC, AND ANTIANGINAL EFFECTS OF PIRSIDOMINE, A NEW SYDNONIMINE, The American journal of cardiology, 77(11), 1996, pp. 937-941
PROLONGATION OF THE PQ INTERVAL AS A MEASURE OF THERAPEUTIC INEQUIVALENCE BETWEEN 2 FORMULATIONS OF DILTIAZEM
Authors: DELLAPASCHOA OE LUCKOW V TRENK D JAHNCHEN E SANTOS SRCJ
Citation: Oe. Dellapaschoa et al., PROLONGATION OF THE PQ INTERVAL AS A MEASURE OF THERAPEUTIC INEQUIVALENCE BETWEEN 2 FORMULATIONS OF DILTIAZEM, European Journal of Clinical Pharmacology, 48(1), 1995, pp. 45-49
PHARMACOKINETICS OF THE CLASS-I ANTIARRHYTHMIC DRUG DIPRAFENONE IN POOR METABOLIZERS OF SPARTEIN DEBRISOQUINE
Authors: JAHNCHEN E BUSCHMANN M TRENK D
Citation: E. Jahnchen et al., PHARMACOKINETICS OF THE CLASS-I ANTIARRHYTHMIC DRUG DIPRAFENONE IN POOR METABOLIZERS OF SPARTEIN DEBRISOQUINE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 151-151
BETA-ADRENOCEPTOR BLOCKING ACTIVITY OF THE ENANTIOMERS OF DIPRAFENONEIN MAN
Authors: TRENK D BUSCHMANN M JAHNCHEN E
Citation: D. Trenk et al., BETA-ADRENOCEPTOR BLOCKING ACTIVITY OF THE ENANTIOMERS OF DIPRAFENONEIN MAN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 167-167
CLINICAL PHARMACOLOGICAL ASPECTS OF THERA PY WITH ENOXIMONE
Authors: TRENK D JAHNCHEN E
Citation: D. Trenk et E. Jahnchen, CLINICAL PHARMACOLOGICAL ASPECTS OF THERA PY WITH ENOXIMONE, Zeitschrift fur Kardiologie, 83, 1994, pp. 7-14
DETERMINATION OF THE ANTIISCHEMIC ACTIVITY OF NEBIVOLOL IN COMPARISONWITH ATENOLOL
Authors: RUF G TRENK D JAHNCHEN E ROSKAMM H
Citation: G. Ruf et al., DETERMINATION OF THE ANTIISCHEMIC ACTIVITY OF NEBIVOLOL IN COMPARISONWITH ATENOLOL, International journal of cardiology, 43(3), 1994, pp. 279-285
PHARMACOKINETICS AND PHARMACODYNAMICS OF RAMIPRIL AND PIRETANIDE ADMINISTERED ALONE AND IN COMBINATION
Authors: RUF G GERA S LUUS HG TRENK D DELAREY N LOFFLER K SCHULTZ W JAHNCHEN E
Citation: G. Ruf et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF RAMIPRIL AND PIRETANIDE ADMINISTERED ALONE AND IN COMBINATION, European Journal of Clinical Pharmacology, 46(6), 1994, pp. 545-550
PHARMACOKINETICS AND HEMODYNAMIC-EFFECTS OF ISDN FOLLOWING DIFFERENT DOSAGE FORMS AND ROUTES OF ADMINISTRATION
Authors: VOGT D TRENK D BONN R JAHNCHEN E
Citation: D. Vogt et al., PHARMACOKINETICS AND HEMODYNAMIC-EFFECTS OF ISDN FOLLOWING DIFFERENT DOSAGE FORMS AND ROUTES OF ADMINISTRATION, European Journal of Clinical Pharmacology, 46(4), 1994, pp. 319-324
LOW-DOSE ALMITRINE BISMESYLATE IN THE TREATMENT OF HYPOXEMIA DUE TO CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
Authors: WINKELMANN BR KULLMER TH KNEISSL DG TRENK D KRONENBERG H
Citation: Br. Winkelmann et al., LOW-DOSE ALMITRINE BISMESYLATE IN THE TREATMENT OF HYPOXEMIA DUE TO CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, Chest, 105(5), 1994, pp. 1383-1391
COMPARISON OF THE EFFECTS OF 2 DIFFERENT GALENICAL PREPARATIONS OF GLYCERYL TRINITRATE ON PULMONARY-ARTERY PRESSURE AND ON THE FINGER PULSECURVE
Authors: BUSCHMANN M WIEGAND A SCHNELLBACHER K BONN R REHE A TRENK D JAHNCHEN E ROSKAMM H
Citation: M. Buschmann et al., COMPARISON OF THE EFFECTS OF 2 DIFFERENT GALENICAL PREPARATIONS OF GLYCERYL TRINITRATE ON PULMONARY-ARTERY PRESSURE AND ON THE FINGER PULSECURVE, European Journal of Clinical Pharmacology, 44(5), 1993, pp. 451-456
DETERMINATION OF THE INTERACTION OF 3S-HYDROXY-10,11-DIHYDROQUINIDINEON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN
Authors: TRENK D MOHRKE W WARTH L JAHNCHEN E
Citation: D. Trenk et al., DETERMINATION OF THE INTERACTION OF 3S-HYDROXY-10,11-DIHYDROQUINIDINEON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN, Arzneimittel-Forschung, 43-2(8), 1993, pp. 836-841
Risultati: 1-25 |